InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Brilon Robert J, 首席财务官. Director active across 3 companies, notably Iveda Solutions, Inc.. In total, 5 reports have been logged. Activity tracked since 7 December 2020. The latest transaction was filed on 27 November 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Brilon Robert J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
500,000 股0Common Stock, par value $0.001SEC:0001493152-23-043071:0
1,287,694 股Common Stock, par value $0.001SEC:0001493152-22-018744:0
4,635,720 股0Common Stock, par value $0.001SEC:0001493152-22-010627:0
200,000 股@ US$0.3763.8% 占其流量Common StockSEC:0001493152-22-000198:0
320,000 股@ US$0.1436.2% 占其流量Common StockSEC:0001493152-21-023791:0
5 条申报中的 5 条
About Brilon Robert J
Robert J. Brilon is the Chief Financial Officer of Iveda Solutions, Inc. and Spine Injury Solutions, Inc. He is responsible for financial management and strategy for these companies, ensuring regulatory compliance and financial health. His expertise is a major asset for their success.
